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Parallel pathways in the folding of a short-term denatured
scFv fragment of an antibody
Christian Freund1,*, Peter Gehrig1, Antonio Baici2, Tad A Holak3 and
Andreas Plückthun1
Background: Antibodies are prototypes of multimeric proteins and consist of
structurally similar domains. The two variable domains of an antibody (VH and
VL) interact through a large hydrophobic interface and can be expressed as
covalently linked single-chain Fv (scFv) fragments. The in vitro folding of scFv
fragments after long-term denaturation in guanidinium chloride is known to be
slow. In order to delineate the nature of the rate-limiting step, the folding of the
scFv fragment of an antibody after short-term denaturation has been investigated.
Results: Secondary structure formation, measured by H/D-exchange
protection, of a mutant scFv fragment of an antibody after short incubation in
6 M guanidinium chloride was shown to be multiphasic. NMR analysis shows
that an intermediate with significant proton protection is observed within the
dead time of the manual mixing experiments. Subsequently, the folding reaction
proceeds via a biphasic reaction and mass spectrometry analyses of the
exchange experiments confirm the existence of two parallel pathways. In the
presence of cyclophilin, however, the faster of the two phases vanishes (when
followed by intrinsic tryptophan fluorescence), while the slower phase is not
significantly enhanced by equimolar cyclophilin.
Conclusions: The formation of an early intermediate, which shows amide-
proton exchange protection, is independent of proline isomerization.
Subsequently, a proline cis–trans isomerization reaction in the rapidly formed
intermediate, producing ‘non-native’ isomers, competes with the fast formation
of native species. Interface formation in a folding intermediate of the scFv
fragment is proposed to prevent the back-isomerization of these prolines from
being efficiently catalyzed by cyclophilin.
Introduction
The in vitro folding of larger proteins consisting of more
than one domain is often a slow process [1,2]. This is dif-
ferent from the behavior of several small proteins, some of
which have been shown to fold fast and with two-state
behavior [3–7]. Disulfide formation and proline isomeriza-
tion are the best known examples of processes leading to
slow folding [8,9], but additional factors related to the
docking and correct annealing of individual domains have
also been shown to be rate limiting for larger proteins
[1,10,11]. It has been observed that refolding conditions
can be crucial for the observation of kinetic intermediates
[12] and that heterogeneity within the unfolded state can
also contribute to the occurrence of intermediate states
[13,14]. The question of whether certain intermediates
actually represent kinetic traps of partially structured mol-
ecules [15], or even soluble aggregates of unfolded protein
[16], has recently come into focus, and such steps might
contribute to slow folding events, especially in larger pro-
teins. In the case of proteins composed of distinct struc-
tural domains, local cooperativity is believed to exist prior
to global cooperativity [17] and it has therefore been pro-
posed that the formation of kinetic intermediates might
simply be a consequence of the existence of more than one
cooperative folding unit within the protein assembly [5].
Antibodies are prototypes of proteins, which consist of
multiple domains, all belonging to the same structural
family [18]. The individual domains can be covalently
linked as in the heavy and light chains of natural antibod-
ies, which show relatively few structural interactions
between adjacent domains. In addition, the domains of dif-
ferent chains are usually non-covalently associated by the
interaction of large, hydrophobic interfaces, as for example
between the two variable domains VH and VL. The interac-
tion of the domains during the refolding of an antibody
light chain has been proposed to lead to a non-additive
folding behavior [19]. For the Fab fragment of an antibody
it has been shown that the association of the two chains
takes place early on in the folding reaction and that proline
isomerization is rate-limiting for the subsequent formation
of the native structure [20]. Proline isomerization has also
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been reported to be rate-limiting for the folding of isolated
variable and constant domains [21,22], but no detailed
information has been available for the formation of struc-
ture in the absence of additional slow steps such as disulfide
bond formation or proline isomerization.
We have chosen the single-chain Fv (scFv) fragment (an
antigen-binding fragment of the topology VH–linker–VL) of
the phosphorylcholine-binding antibody McPC603 as a
model system for our studies. The assignment of most of
the backbone NH resonances of this two-domain β-sheet
protein has been completed [23] and has allowed us to
analyze the kinetic H/D exchange experiments by NMR
methods. H/D exchange experiments and their analysis by
NMR and mass spectrometry (MS) have become a very
useful tool for the study of protein folding. MS provides
information on the population of species with different
amide-proton protection at certain time points [24], whereas
NMR allows the kinetic analysis of individual amide-proton
protection along the folding pathway [25,26]. Previously, we
investigated the formation of H/D protection during the
refolding of the equilibrium-denatured oxidized scFv frag-
ment [27,28] and identified a rapidly formed intermediate,
which shows some degree of amide-proton protection. The
completion of folding from this intermediate was shown to
be a slow, cooperative process involving both domains.
In the current study, we analyzed the refolding of a short-
term denatured scFv fragment in order to delineate the role
of proline cis–trans isomerization both for the formation of
this intermediate and for the slow folding reaction. Because
the VL domain of the scFv fragment under investigation
carries two cis prolines in the native structure [29], one of
them being in CDR3 of the light chain where it makes
several crucial contacts in the interface to the heavy chain,
it seemed likely that proline isomerization might be
involved in the rate-limiting steps of the folding reaction
and native interface formation. Double-jump experiments,
in which the protein is denatured only for a short time
before refolding, in order to keep the prolines in a native-
like conformation, were performed and analyzed by NMR,
MS and fluorescence spectroscopy. Our results suggest that
formation of an early intermediate is independent of proline
conformations, but that folding from the intermediate with
‘native-like’ proline isomers competes with proline isomer-
ization. As a consequence of the formation of non-native
proline isomers, a folding intermediate with a non-native
interface between VH and VL is formed. This trapped inter-
mediate converts to the native state in an ~10-fold slower
reaction than the formation of native species from the
earlier intermediate with native-like proline isomers.
Results
Unfolding reaction
The unfolding reaction is biphasic at lower guanidinium
chloride (GdnCl) concentrations, but becomes monophasic
at 4 M GdnCl (Figure 1; the rate constant for unfolding
k = 2.54 ± 0.02 s–1 at 10°C). For the short-term denaturation
(double-jump) experiments, the native scFv fragment was
denatured for 20 s on ice in 6 M GdnCl so that the unfold-
ing reaction and proton exchange of the unfolded protein
[30,31] is completed, but proline isomerization should not
have taken place to a significant degree [32–35].
Double-jump H/D experiments of the scFv fragment and
their analysis by NMR
In order to resolve the folding pathway in terms of individ-
ual amide groups, we performed H/D exchange experi-
ments and analyzed these experiments by NMR. A scFv
fragment bearing the mutations Pro40→Ala, Ser63→Ala
and Ala64→Asp was mostly used because this mutant was
shown to be less prone to thermal aggregation [36]. NMR
investigations of the native state of this mutant protein
confirmed that the structure is changed only at the site of
mutation and that the HSQC spectra of mutant and wild-
type (wt) protein are otherwise superimposable, allowing
the assignment to be transferred. It was also confirmed
that the same folding intermediate with respect to amide-
proton protection is populated for the mutant and the wt
protein (see below). Differences in the rates of folding
between mutant and wt protein are small but significant
(see below).
For the kinetic H/D experiments, the native 15N-labeled
scFv fragment was diluted 10-fold into 6.6 M GdnCl/
D2O at pH 8.0 and incubated for 20 s on ice to denature
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Figure 1
A fluorescence trace for the unfolding of the wild-type (wt) scFv
fragment in 4 M GdnCl at 10°C. The rate constant for unfolding
k = 2.54 ± 0.02 s–1 at 10°C.
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and deuterate the protein. Next, the protein was further
diluted 100-fold into refolding buffer, containing 0.4 M
arginine, 20 mM borate, 1 mM phosphorylcholine, pDread =
8.0 (pDread: the value directly read from the pH electrode),
in D2O. After various refolding times (10 s, 30 s, 60 s, 120 s,
300 s and 600 s), this solution was mixed with 6.25 volumes
of 0.12 M potassium phosphate buffer, 1 mM phosphoryl-
choline, pH 4.0, to result in a final pH of 5.1. At this pH,
exchange of amide protons with significant protection
factors should be slow, while the exchange of unprotected
amide groups should take place with a rate high enough,
compared to the refolding reaction, to allow fast protona-
tion of these residues. After completion of folding at this
pH, samples were concentrated, dialyzed and lyophilized
prior to dissolution in D2O and acquisition of 15N–1H cor-
relation spectra. In Figure 2, representative plots of the
signal intensity of amide protons in the HSQC spectra
versus time for refolding in D2O (before dilution into H2O)
are shown. The curves were fitted by double-exponential
functions, and a summary of the rates and amplitudes
obtained is given in Table 1. For some residues (examples
are given in Figure 2a) the six time points could be fitted
well by a double-exponential function. For many residues,
however, there is a large loss of signal intensity already
within the dead time of the manual mixing experiment
(examples are given in Figure 2b,c). The initial rapid
decrease at some positions argues for the formation of an
exchange-protected intermediate within the dead time of
the experiment, as was observed for the equilibrium-dena-
tured protein [27].
In Table 1, the proton occupancies after 10 s of refolding in
D2O are shown for the VH and the VL domains. The most
prominent reduction of proton occupancies is observed for
residues of the inner β sheet of the VL domain (positions
40–43, 54 and 90–93). For the VH domain, a few residues
(positions 34, 82 and 95) also display largely reduced
proton occupancies (Table 1). The observed pattern of
proton occupancies is very similar to the pattern found
within the intermediate of the refolding reaction of the
equilibrium-denatured protein [27], suggesting that the
same intermediate is formed in both experiments. In con-
trast to the refolding of the equilibrium-denatured protein,
however, the reaction from the intermediate to the native
state becomes biphasic for the short-term denatured
protein. Due to the additional fast phase in the manual
mixing experiments, the absolute values for the proton
occupancies after 10 s of refolding are lower for the short-
term denatured protein than for the equilibrium-denatured
protein (see Table 1 and reference [27] for comparison).
For the residues with no or small protection within the
intermediate, this first rate constant could be estimated
and an average rate constant of 0.05 s–1 was obtained. The
second rate has an average value of 0.0014 s–1 and is similar
to the rate of protection from exchange of the equilibrium-
denatured protein (data not shown). This argues for the
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Figure 2
Plots of signal intensity versus refolding time in D2O for representative
residues of the Pro40→Ala/Ser63→Ala/Ala64→Asp mutant scFv
fragment. Double exponential fits are shown as lines. See text for more
details. The residues are from the VH (H) and VL (L) domains.
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Table 1
Rate constants and amplitudes for the decay of NMR signal intensity with time of refolding.
A1 A2 Proton occupancy after
Residue k1 (s–1) (signal intensity) k2 (× 10–3 s–1) (signal intensity) 10 s refolding
Leu4(H) — 79.7 ± 3.0 1.4 ± 0.2 37.2 ± 2.1 0.41
Val5(H) — 131.0 ± 6.3 1.4 ± 0.2 124.6 ± 4.5 0.59
Ser21(H) 0.05 ± 0.02 39.0 ± 9.0 1.3 ± 0.3 79.2 ± 8.0 0.86
Met34(H) — 51.1 ± 3.1 — 22.9 ± 5.8 0.26
Gln39(H) — 46.4 ± 2.0 2.2 ± 0.1 60.7 ± 1.4 0.63
Ile48(H) — 29.3 ± 4.3 2.0 ± 0.5 30.0 ± 3.1 0.57
Ala49(H) 0.06 ± 0.01 40.0 ± 3.4 2.1 ± 0.2 82.6 ± 3.1 0.83
Ala50(H) — 27.1 ± 6.2 2.2 ± 0.4 53.4 ± 4.5 0.69
Ser51(H) 0.03 ± 0.02 23.2 ± 10.6 2.4 ± 0.5 80.2 ± 10.4 0.98
Glu61(H) 0.05 ± 0.01 36.6 ± 4.2 0.7 ± 0.2 52.3 ± 3.5 0.79
Ala63(H) 0.05 ± 0.01 40.7 ± 5.1 1.8 ± 0.2 80.1 ± 4.7 0.85
Phe70(H) 0.09 ± 0.02 58.3 ± 4.9 1.6 ± 0.2 92.6 ± 4.0 0.75
Ile71(H) — 58.6 ± 2.1 2.3 ± 0.2 42.0 ± 1.5 0.48
Ser73(H) 0.03 ± 0.006 52.0 ± 4.7 1.7 ± 0.2 87.7 ± 4.5 0.88
Asp75(H) — 56.1 ± 8.9 1.8 ± 0.4 73.6 ± 6.6 0.65
Tyr82(H) — 59.5 ± 3.4 — 15.6 ± 2.6 0.24
Gln84(H) — 81.6 ± 4.7 2.1 ± 0.3 62.3 ± 3.4 0.5
Arg89(H) — 46.7 ± 4.9 1.8 ± 0.3 64.0 ± 3.5 0.63
Asp92(H) 0.07 ± 0.03 53.6 ± 9.8 1.9 ± 0.3 105.7 ± 8.5 0.79
Ile95(H) — 78.5 ± 1.3 — 10.7 ± 0.8 0.19
Val118(H) — 30.3 ± 2.0 2.0 ± 0.2 39.7 ± 1.4 0.57
Thr119(H) 0.06 ± 0.02 53.0 ± 7.6 1.3 ± 0.3 73.1 ± 6.6 0.79
Val120(H) 0.07 ± 0.04 33.5 ± 7.9 1.1 ± 0.3 64.1 ± 6.6 0.78
Leu11(L) 0.05 ± 0.01 52.8 ± 4.2 0.6 ± 0.1 86.0 ± 3.5 0.84
Val13(L) 0.09 ± 0.03 57.4 ± 6.7 0.8 ± 0.1 135.8 ± 5.2 0.81
Glu17(L) 0.07 ± 0.02 74.6 ± 10.5 0.6 ± 0.2 130.0 ± 8.4 0.80
Thr20(L) — 143.1 ± 10.6 1.5 ± 0.2 144.7 ±7.8 0.61
Cys23(L) 0.06 ± 0.02 35.9 ± 5.9 1.7 ± 0.3 58.0 ± 5.3 0.79
Ala40(L) — 66.7 ± 0.6 2.1 ± 0.1 23.0 ± 0.4 0.30
Trp41(L) — 81.8 ± 2.0 — 18.8 ± 4.2 0.18
Tyr42(L) — 71.6 ± 2.8 — 11.6 ± 1.8 0.19
Gln43(L) — 58.6 ± 1.0 1.9 ± 0.1 36.2 ± 0.7 0.43
Ile54(L) — 63.7 ± 0.8 — 27.2 ± 0.5 0.52
Phe68(L) 0.08 ± 0.05 64.1 ± 16.3 1.2 ± 0.4 120.6 ± 13.5 0.78
Thr69(L) 0.04 ± 0.01 52.9 ± 5.8 1.5 ± 0.2 88.6 ± 5.3 0.89
Phe77(L) — 26.0 ± 2.4 0.3 ± 0.1 63.7 ± 1.6 0.75
Thr78(L) — 59.1 ± 3.2 1.0 ± 0.1 64.5 ± 2.4 0.66
Ile81(L) — 92.0 ± 3.2 1.8 ± 0.3 43.0 ± 2.3 0.40
Val84(L) 0.03 ± 0.01 16.6 ± 1.5 1.4 ± 0.1 55.1 ± 1.4 0.93
Gln85(L) — 63.6 ± 6.6 1.4 ± 0.2 86.4 ± 4.6 0.63
Ala86(L) — 42.2 ± 8.0 1.3 ± 0.4 59.9 ± 5.9 0.69
Asp88(L) — 110.4 ± 9.0 1.0 ± 0.2 147.9 ± 6.6 0.68
Ala90(L) — 137.3 ± 2.2 0.9 ± 0.1 39.7 ± 1.4 0.25
Val91(L) — 133.0 ± 1.8 — 18.9 ± 1.2 0.24
Tyr93(L) — 76.5 ± 3.8 — 13.0 ± 7.7 0.14
Cys94(L) — 53.1 ± 3.2 — 39.6 ± 2.0 0.49
Lys109(L) 0.04 ± 0.01 36.5 ± 5.4 0.6 ± 0.2 75.3 ± 4.6 0.89
Leu110(L) 0.09 ± 0.02 50.1 ± 5.2 1.4 ± 0.2 85.4 ± 4.2 0.76
Rates of the fast refolding phase (k1) have been omitted if the loss of amplitude (A1, measured as peak heights — signal intensity — of the respective
NMR signal) due to the intermediate formation in the first time point is too large for an accurate determination. Rates of the second refolding phase
(k2) have been omitted if the corresponding amplitude (A2) was very small compared to the overall amplitude. H, a residue in the VH domain; and L,
a residue in the VL domain.
same folding process to take place for the single slow phase
of folding for the equilibrium-denatured protein and the
second phase of the double-jump experiments.
MS analysis of H/D experiments
In order to investigate the population of proton
exchange-protected species along the folding pathway,
we performed a similar series of H/D exchange experi-
ments with the short-term denatured scFv fragment as
described in the preceding section and analyzed the
experiments by MS. From these experiments it should
be distinguishable, whether the first phase of proton pro-
tection observed within the NMR experiments leads to a
second, sequentially formed intermediate, or whether
this phase corresponds to the fast formation of native or
native-like protein for a subset of molecules. The results
for the short-term denatured protein are shown in
Figure 3. After 10 s of refolding a broad peak with an
average mass of 27150 Da is observed, indicating that
multiple species are populated. After 2 min, however,
two major species remain, one 42 mass units higher than
the protonated reference state and the second with the
mass of the native species (27175 Da), which is 87 mass
units higher than the protonated reference state. After
10 min, the species with the mass of the native protein is
populated by ~85% of the molecules, leaving 15% of
molecules with the mass of the intermediate.
These findings clearly favor the model of two parallel path-
ways. If a sequential mechanism were operative, a second
highly populated intermediate should be observed after
1–2 min, according to the NMR experiments. The forma-
tion of a species with native-like protection should occur
with a rate constant of 0.0014 s–1 (the rate constant of the
second phase of the NMR experiments). This rate con-
stant would predict that 50% of the molecules have native
protection after 495 s. What we observe, however, is that
half of the molecules are already fully protected after 120 s.
This is exactly what one would expect, if two parallel path-
ways with rate constants of 0.06 s–1 (amplitude: 35%) and
0.0014 s–1 (amplitude: 65%) are assumed. Because in the
NMR experiments similar rate constants and amplitudes
were found from the average values for those residues that
could be fitted well by a double exponential (see Table 1),
and because all residues in the NMR experiments display
a significant amplitude for the first phase, we propose par-
allel pathways of secondary structure stabilization, when
folding is started from short-term denatured protein.
Mutant versus wild-type scFv fragment folding
The mutant used in this study, Pro40→Ala/Ser63→Ala/
Ala64→Asp, was shown to result in higher expression
yields in Escherichia coli than the wt scFv fragment [36].
In addition, the amount of scFv fragment obtained by
preparative in vitro folding was also shown to be signifi-
cantly enhanced for the mutant protein (C.F. and A.P.,
unpublished observations). Because the thermodynamic
stability was shown to be the same within experimental
error for wt and mutant protein [36], and because the
thermal aggregation rate was higher for the wt protein, it
was concluded that a difference in the rate of off-pathway
reactions might be primarily responsible for different in
vivo yields. We therefore wanted to compare the in vitro
folding behavior of the two proteins in greater detail.
Because we wanted to be able to detect even small changes
in the rate constants for the proton protection during the
folding reaction, we measured both proteins under exactly
the same conditions. This can be achieved by MS analysis
of H/D exchange protection during folding if the mass dif-
ference of the two proteins is large enough to allow com-
plete separation of the peaks but still allows the detection
of the same number of charged species within a certain
m/z range. Because the wt and mutant scFv fragment
have almost identical molecular weight (1 Da difference),
15N-labeled protein was used for the mutant in the experi-
ments. A mass spectrum of a mixture of the equilibrium-
denatured wt and mutant scFv fragment is shown in
Figure 4a and shows that the peaks are well separated.
The masses of the protonated reference samples corre-
spond well with the theoretical masses. During the whole
folding reaction, a total of 76 protons become protected. As
can be seen from Figure 4, the protection proceeds with a
higher rate for the mutant protein, for which the fully pro-
tected species is exclusively populated after 30 min,
whereas there is still a significant amount of intermediate
species for the wt protein. We therefore conclude that the
three mutations in the VH domain affect the net rate of
secondary structure stabilization.
In addition, H/D exchange of the short-term denatured wt
scFv fragment was monitored by NMR. The decay of
NMR signal intensity of representative amide protons
with the time of refolding is shown in Figure 5. As for the
mutant protein (Figure 2), the protection of all residues
shows a biphasic behavior. A close inspection of the
degree of protection after 10 s of refolding reveals that the
proton occupancies are very similar for the two proteins.
What is different, however, is the second, slow phase of
proton protection, which appears significantly slower for
the wt protein. This was independently confirmed by MS
analysis of the H/D exchange protection during the refold-
ing of the short-term-denatured proteins (data not shown).
The three mutations within the VH domain might affect
the slow folding rate either by stabilization of the domain
itself, thus leading to a higher frequency of productive
encounters with VL to form the correct interface, or else
indirectly by changing the nature or population of inter-
mediates along the slow folding pathway. Another possi-
bility is that the wild-type protein forms some reversible
aggregates during these folding experiments, as has been
demonstrated for a number of larger proteins with slow
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folding behavior [2,37]. Such aggregate formation would
presumably slow down productive formation of the wt
scFv fragment, whereas the mutant with the improved
folding properties undergoes no such side reaction. Our
results indicate, however, that these multimeric forms, if
they exist, do not change the amide protection pattern of
the initially formed folding intermediate.
Influence of cyclophilin on the rate of folding
Figure 6c shows the refolding reaction of the long-term
denatured protein as measured by fluorescence at 331.4 nm,
the wavelength maximum of the native scFv fragment in
the presence of antigen. There is an initial loss of inten-
sity, which cannot be resolved properly by manual mixing
experiments. The subsequent gain of fluorescence can be
fitted by a single exponential function (k = 0.0008 s–1),
but the gain of fluorescence in the refolding of the short-
term denatured protein becomes biphasic (Figure 6a)
with rate constants of 0.0061 s–1 and 0.00054 s–1. Because
the gain in fluorescence has been interpreted as forma-
tion of the native interface of the two variable domains
[27,38], we suggest parallel pathways in the refolding of
44 Folding & Design Vol 3 No 1
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MS analysis of the short-term denatured Pro40→Ala/Ser63→Ala/Ala64→Asp mutant scFv fragment after various times of refolding in D2O buffer.
(a) Reconstructed hypermass of the protonated protein, and hypermass after (b) 10 s, (c) 2 min and (d) 10 min of refolding.
the short-term denatured scFv fragment to account for
the observed biphasic behavior.
To test whether proline isomerization is involved in the
folding of the short-term denatured protein, we added
cyclophilin, a proline cis–trans isomerase, to the refolding
buffer. In Figure 6b, the folding reaction of the short-term
denatured scFv fragment in the presence of equimolar
cyclophilin is shown. Interestingly, the gain of fluorescence
becomes monophasic again (k = 0.0013 s–1), as it does for
the long-term denatured protein (see Figure 6c). This sug-
gests that the initially native-like prolines in the dena-
tured scFv fragment isomerize to the ‘wrong’ conformer in
competition with the refolding reaction and that this iso-
merization can be catalyzed efficiently by cyclophilin. A
similar observation has been made for carbonic anhydrase
[32] and a Fab fragment [39]. It has been proposed by
Kern et al. [32] that the isomerization of prolines within an
intermediate, rather than in the unfolded state, competes
with the refolding reaction. We also examined these two
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Figure 4
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Analysis of H/D protection of the Pro40→Ala/Ser63→Ala/Ala64→Asp mutant in comparison to the wt scFv fragment by MS. (a) 15N-labeled
protein was used in the case of the mutant in order to achieve mass separation of both proteins; (b) the protonated reference samples; and (c) and
(d) the hypermass of the species after 2 min and 30 min of refolding, respectively.
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Figure 5
Plots of NMR signal intensity versus refolding time in D2O for
representative residues of the wt scFv fragment. Double exponential
fits are shown as lines. See text for more details.
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Figure 6
Fluorescence traces of the short-term denatured wt scFv fragment in
(a) the absence and (b) the presence of a 2:1 excess of cyclophilin.
(c) Refolding of the long-term denatured protein for comparison [25].
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possibilities: on the one hand, the length of the denatura-
tion time was altered, without affecting the amplitudes of
the two phases or the rates significantly (data not shown);
and on the other hand, when cyclophilin was added after
the initiation of folding, the faster of the two phases could
still be abolished to a large degree (data not shown). In
addition, the effect of cyclophilin could be totally over-
come by the addition of the inhibitor cyclosporin A to the
refolding buffer, excluding non-specific interactions of
cyclophilin with the scFv fragment to be the reason for our
observations. We therefore conclude that proline isomer-
ization takes place within a folding intermediate of the
short-term denatured scFv fragment and competes with
the refolding reaction. Because there are two cis prolines in
the VL domain of the native scFv fragment, it is most prob-
able that one or both of these two prolines are involved in
this isomerization reaction.
Discussion
The results of the current study show that the stabilization
of secondary structure during the folding of the scFv frag-
ment of an antibody after short-term denaturation can
proceed along two parallel pathways. Measurements of the
intrinsic tryptophan fluorescence of the short-term dena-
tured protein during the folding reaction also reveals the
existence of fast folding and slow folding species, although
the rate constants are smaller than the rates obtained from
the H/D experiments (0.06 s–1 versus 0.006 s–1 and 0.0013
versus 0.00054 s–1). This difference at first appears to indi-
cate that secondary structure formation precedes the forma-
tion of the native interface (which the fluorescence
measurements are indicative of), but caution has to be
taken to avoid overinterpretation of the rates of the H/D
exchange experiments because they rely on a relatively
small number of points. The H/D exchange experiments
confirm the existence of an early folding intermediate, with
an enhanced degree of amide-proton protection within
certain regions of the β sheets [27,28], very similar to the
results from the refolding of long-term denatured protein.
Upon addition of equimolar cyclophilin to the refolding
buffer of the short-term denatured protein, the faster of the
two phases of fluorescence gain vanishes completely. The
enzyme obviously catalyzes a proline isomerization reac-
tion that competes with the correct folding of the fast
folding species. We suggest that the fast folding molecules
of the uncatalyzed reaction refold from the early formed
intermediate with all prolines in a native-like conforma-
tion. We further propose that the enzyme acts on one of
the two native-like cis prolines (or both) in the early folding
intermediate rather than the unfolded state, because the
enzyme’s action could still be observed if it was added
after the start of the refolding reaction.
For the slowly folding molecules, no significant rate
enhancement was observed in the presence of equimolar
amounts of cyclophilin. In contrast, the slow folding of the
isolated VL domain, which carries two cis prolines (whereas
VH has none [29]), can be increased in the presence of
equimolar amounts of PPI (peptidyl-prolyl cis-trans iso-
merase; [27]). Only at high concentrations of PPI is a rate
acceleration seen in the refolding of both short-term dena-
tured and long-term denatured scFv fragment [38]. We
therefore propose that in the folding of the scFv fragment
non-native domain association takes place after back-iso-
merization of native-like cis prolines. As a consequence, at
least one proline becomes poorly accessible for the
enzyme in this domain-associated intermediate. Because
folding from this intermediate state with non-native
proline isomers takes much longer than the folding from
the earlier intermediate state with native-like prolines, we
consider the former to be a kinetic trap along the folding
pathway of the scFv fragment. At equimolar concentra-
tions, cyclophilin efficiently catalyzes the formation of this
trapped intermediate, but not its conversion to the native
state. When equilibrium unfolded scFv is refolded, the
future cis prolines of the VL domain are largely in the non-
native trans conformation and therefore escape the action
of the enzyme due to non-native interface formation.
Early domain association of immunoglobulin domains has
also been demonstrated for the Fab fragment of an anti-
body [39] and the rate-limiting step was shown to be pro-
line isomerization within the association complex. Early
formation of a non-native interface therefore seems to be
a more general feature for the folding of larger fragments
of immunoglobulins in vitro, especially if the effective
concentration of domains is enhanced by covalent linkage.
Most strikingly, our results suggest that early domain associ-
ation can hinder the fast folding of a two-domain protein. As
a consequence of the formation of wrong proline isomers,
an intermediate is formed that probably has an interface
with (partly) non-native interactions and that prevents inde-
pendent domain folding. Because similar rate constants for
the slow phase of amide protection are observed for the
residues of the two domains, folding from this kinetically
trapped intermediate to the native state seems to be a com-
mitted step. In contrast to a truly cooperative folding
behavior, however, in which the rates of folding for the
scFv fragment should be enhanced as a result of favorable
interactions of the individual domains, the folding process is
in fact slowed down by the covalent linking of domains in
the scFv fragment as a result of allowed unfavorable inter-
actions early in the process. Similar observations of
inhibitory domain interactions during folding have been
made for phosphoglycerate kinase [40]. In contrast, single-
chain Arc repressor folds faster than the non-covalent dimer
by increasing the effective concentration of subunits [41].
The situation is different in vivo because the heavy and
light chains are synthesized separately and interact with
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chaperones like BiP and Grp94 [42]. It is therefore probable
that the interaction of the two variable domains takes place
from a native or native-like conformation of the individual
domains. Our results suggest that for the fast formation of
native antibodies it might be crucial that the interaction of
VL and VH does not take place early during the folding of
the individual domains. The interaction of the two native
domains is in the micromolar range [43] and is made up pri-
marily by hydrophobic interactions. The involvement of
many hydrophobic sidechains may allow many energetically
favorable, but non-native, interactions at the interface of
the two domains and therefore slow down the folding rates.
These non-native interactions probably compete with the
correct folding of the single domains.
The formation of an exchange-protected intermediate is
very fast [28] and, as our results suggest, is independent of
the conformation of the prolines in the folding intermedi-
ate. The same protection pattern is observed in the dead
time of manual mixing in this study as for folding studies
of the long-term denatured protein [27,28]. Protection of
amide protons of hydrophobic residues mainly located in
the inner β sheets of the individual domains might there-
fore be an inherent feature of the single domains. On the
other hand, formation of stabilized secondary structure
within those β sheets that make up the future interface
might facilitate the formation of stable, but kinetically
trapped, intermediates, as observed for the scFv fragment
investigated in this study.
Materials and methods
Protein preparation
The wt and mutant scFv fragments were obtained by refolding from
inclusion bodies in E. coli as described before [44].
Fluorescence measurements
Fast unfolding kinetics were followed by stopped-flow fluorescence,
using an SF61 spectrofluorimeter (HI-TECH Scientific, Salisbury, UK)
equipped with a 0.25 ml and a 5.0 ml syringe, to produce a fixed dilu-
tion of 1:20. The excitation wavelength was set to 280 nm and the
emission light passed through a 320 nm cut-off filter (WG-320, HIGH-
TECH Scientific). The native protein in 50 mM borate, 20 mM NaCl,
1 mM phosphorylcholine, pH 8.0 was filled into the small volume
syringe, and denaturant solutions containing 20 mM borate and differ-
ent amounts of GdnCl were filled into the second syringe. The experi-
ments were carried out at 10°C. The final protein concentration was
2 µM. The experimental curves were fitted by one or two exponential
functions with the Kaleidagraph software on a Macintosh computer.
The fluorescence traces of the folding of short-term denatured scFv frag-
ment were measured on a PTI machine with the excitation wavelength at
295 nm and the emission set to 331.4 nm, the wavelength maximum of
the native protein. Native scFv fragment at a concentration of 100 µM was
diluted 10-fold into 6.6 M GdnCl, stored for 20 s on ice and the mixture
was further diluted 50-fold into the pre-cooled refolding buffer within the
fluorescence cuvette containing 35 mM HEPES, 50 mM NaCl, pH 8.0. In
a second experiment, an equimolar amount of human cyclophilin was
added to the refolding buffer. Experiments were performed at 10°C.
H/D exchange experiments
For each time point of the H/D exchange kinetics purified scFv frag-
ment (5–6 mg 15N-labeled protein for the NMR analysis or a mixture of
0.5 mg of 14N-labeled wt-scFv and 0.5 mg 15N-labeled mutant scFv
fragment for the MS analysis) in 50 mM borate, 20 mM NaCl, 1 mM
phosphorylcholine, pH 8.0 was denatured by a 10-fold dilution into
6.6 M GdnCl, 20 mM borate, pDread = 8.0, in D2O for 20 s on ice. To
initiate folding, the protein solution was then diluted 1:100 into 0.4 M
arginine, 1 mM phosphorylcholine, pDread = 8.0, in D2O. After defined
periods of time, a further 1:6.25 dilution into an H2O buffer containing
0.12 M potassium phosphate, 1 mM phosphorylcholine, pH 4.0 was
performed. The final pH was 5.1. For the protonated reference
sample, the first dilution was done into H2O buffer at pH 8.0 to allow
all amide deuterons to exchange. The reaction was then allowed to
proceed to completion (4 h at 10°C). After concentration of the solu-
tion using an Amicon A8200 cell, the protein was dialyzed against
5 mM KH2PO4 buffer for the NMR analysis and against 10 mM ammo-
nium acetate buffer, pH 5.2, for the MS analysis. For the NMR analy-
sis, the samples were then lyophilized and dissolved in D2O 12 h prior
to acquisition of the data in order to get rid of the fast exchanging
amide protons. For the MS experiments, the dialyzed samples were
further concentrated with a Centricon-10 concentrator and stored on
ice before the measurement.
MS analysis
ESI-MS was used to determine the molecular mass of the scFv
samples, which were injected into the ion source of a Sciex API III+
instrument (Sciex, Ontario, Canada). The ion spray voltage was
~5000 V and the nebulizer gas pressure was 50 psi. The lyophilized
samples were dissolved in ice-cold 10 mM ammonium acetate buffer,
pH 5.0 and were mixed in a 1:1 ratio with an ice-cold mixture of 49.5%
methanol, 49.5% H2O, 1% formic acid to result in a final pH of ~3.0.
5 µl of the mixture were flow-injected into a cooled carrier solution,
consisting of the abovementioned methanol/H2O/formic acid mixture.
The pH of 3.0 and the use of ice-cold solutions throughout the experi-
ment was shown to minimize back-exchange of the protein samples
upon denaturation within the mass spectrometer [28]. A m/z range of
1200–2400 was scanned with a step size of 0.15.
NMR spectra
All spectra were recorded on a Bruker DRX 600 spectrometer
equipped with a Z-gradient unit. The temperature was 27°C and the
samples were dissolved in D2O. Relative protein concentrations were
determined by comparing the methyl resonances at –1.0 ppm in
1D spectra recorded with 64 scans. 15N–1H correlation spectra were
recorded using a gradient enhanced version of a HSQC experiment
[45]. The carrier was positioned on the water resonance. Residual
water suppression was achieved by the application of a WATERGATE
3–9–19 refocusing pulse [46] with a pulse interval of 200 ms in the
final BACK INEPT step, allowing optimal inversion of the amide reso-
nances. The gradient strengths were 25%, 10% and 80% of a
maximum gradient power of 30 G/cm for the gradients G1, G2 and G3,
respectively. The delay for transferring proton magnetization to nitrogen
in the INEPT step was set to 2.25 ms. Decoupling during aquisition
was achieved using the GARP pulse sequence [47]. To obtain phase
sensitive spectra, the TPPI method was used [48]. A data matrix of
4K × 128 points was acquired. Data were processed to a final size of
2K × 256 points using the in-house written software CC-NMR [49].
For each peak analyzed in the HSQC spectra, the corresponding peak
in the reference spectrum was chosen to represent 100% proton
occupancy. The intensities of the peaks were determined by measuring
the peak heights because the line widths of individual peaks did not
change in the spectra of different samples. Errors, which were esti-
mated from the standard deviation of noise in ‘empty’ portions of the
spectrum, were < 10%. Rate constants for the individual peaks were
determined by applying double exponential fits to the plots of signal
intensities (measured as peak heights) versus time of folding (until the
dilution step into H2O, see above), leaving out the 0 time point
because the formation of an intermediate leads to a jump in signal
reduction after 10 s for some protons, independent of the subsequent
folding reactions.
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